In fact, miR-28-5p targets two genes included in this pathway, namely Insulin-like growth factor-I (IGF-I) and serum response factor (SRF), both related to sarcopenia and that play a role as regulators of muscle atrophy (21, 35–38). The gene discussed is IGF1; the disease is sarcopenia.